Bocci Velio, Travagli Valter, Zanardi Iacopo
Department of Physiology, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
Cardiovasc Hematol Disord Drug Targets. 2009 Jun;9(2):78-85. doi: 10.2174/187152909788488681.
In an aging population vascular disorders well exemplified by the chronic limb ischemia, chronic heart failure, cerebral ischemia and age-related macular degeneration represent a serious medical and socio-economical problem. While there is always a not easily identifiable first pathogenic noxa, all of these diseases are characterized by ischemia, chronic inflammation and tissue degeneration. Orthodox medicine has provided several optimal drugs targeting various pathological situations but, even with their concomitant applications, it is not possible to reduce the chronic oxidative stress. Here it is proposed to associate the approach of ozonated autohemotherapy as a modifier of the biological response capable to block the pathological progress.
在老龄化人口中,以慢性肢体缺血、慢性心力衰竭、脑缺血和年龄相关性黄斑变性为典型代表的血管疾病是一个严重的医学和社会经济问题。虽然始终存在一个不易识别的初始致病因素,但所有这些疾病都具有缺血、慢性炎症和组织变性的特征。传统医学已经提供了几种针对各种病理情况的最佳药物,但即使同时应用这些药物,也无法降低慢性氧化应激。在此建议将臭氧自血疗法作为一种能够阻断病理进展的生物反应调节剂联合应用。